Immix Biopharma Inc. logo

Immix Biopharma Inc. (IMMX)

Market Open
15 Dec, 20:28
NASDAQ (CM) NASDAQ (CM)
$
6. 22
-0.85
-12.02%
$
144.37M Market Cap
- P/E Ratio
0% Div Yield
1,774,009 Volume
-0.93 Eps
$ 7.07
Previous Close
Day Range
6.06 7.17
Year Range
1.34 7.45
Want to track IMMX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 72 days
Name Time Cons. EPS Eps
Immix Biopharma Inc. logo
IMMX Immix Biopharma Inc.
25 Feb 2026 (In 2 months)
-
-
Immix Biopharma Inc. logo
IMMX Immix Biopharma Inc.
3 Dec 2025
-
-
Immix Biopharma Inc. logo
IMMX Immix Biopharma Inc.
11 Nov 2025
-
-
Immix Biopharma Inc. logo
IMMX Immix Biopharma Inc.
3 Sep 2025
-
-
Immix Biopharma Inc. logo
IMMX Immix Biopharma Inc.
11 Aug 2025
-
-
Immix Biopharma Inc. logo
IMMX Immix Biopharma Inc.
7 May 2025
-
-
Immix Biopharma Inc. logo
IMMX Immix Biopharma Inc.
9 Nov 2024
-
-
Immix Biopharma Inc. logo
IMMX Immix Biopharma Inc.
11 Aug 2024
-
-
Immix Biopharma Inc. logo
IMMX Immix Biopharma Inc.
9 May 2024
-
-
Immix Biopharma Inc. logo
IMMX Immix Biopharma Inc.
29 Mar 2024
-
-
Immix Biopharma Inc. logo
IMMX Immix Biopharma Inc.
28 Feb 2024
-
-
Immix Biopharma Inc. logo
IMMX Immix Biopharma Inc.
29 Nov 2023
-
-
Immix Biopharma Inc. logo
IMMX Immix Biopharma Inc.
13 Nov 2023
-
-

IMMX Earnings Reports FAQ

What is the earnings per share (EPS) for IMMX?

The current EPS is -0.93.

What is the company's earnings growth rate?

Immix Biopharma Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-25, based on the IMMX's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Immix Biopharma Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for IMMX at this time, as Immix Biopharma Inc has no recent EPS data to calculate it.